INTERNATIONAL PATENT: THE JOHNS HOPKINS UNIVERSITY FILES APPLICATION FOR "CYTOTOXIC SYNERGY OF CRISPR-CAS9 WITH DNA DAMAGE REPAIR INHIBITORS"

GENEVA, Nov. 5 -- THE JOHNS HOPKINS UNIVERSITY (3400 North Charles StreetBaltimore, Maryland 21218) filed a patent application (PCT/US2025/025599) for "CYTOTOXIC SYNERGY OF CRISPR-CAS9 WITH DNA DAMAGE REPAIR INHIBITORS" on Apr 21, 2025. With publication no. WO/2025/226592, the details related to the patent application was published on Oct 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ESHLEMAN, James R. (c/o The Johns Hopkins University3400 North Charles StreetBaltimore, Maryland 21218), TEH, Selina Shiqing K. (c/o The Johns Hopkins University3400 North Charles StreetBaltimore, Maryland...